The Minister of Health announces the objective of availability and reimbursement of the saliva test in 2025
The Minister of Labor, Health and Solidarity, Catherine Vautrin, declared Thursday that the government was targeting the year 2025 for the provision and reimbursement of a saliva test to detect endometriosis. Between 10,000 and 20,000 women should benefit from this reimbursement.
Validation by the High Authority of Health required
“This is our objective, but it requires final validation by the High Authority for Health,” said the Minister of Health on France 2. Before getting to the French test from the company Ziwig, which costs around 1,000 € according to the minister, we must await the results of a new clinical study involving 3,000 women. “After this campaign, the government will be able to allocate the budget which will allow 10,000 or 20,000 women of tomorrow to benefit from the reimbursed test,” she added.
The ENDOmind association welcomes this progress but highlights an underestimate of needs
One of the main associations of patients with endometriosis, ENDOmind, welcomed the possibility for French women to benefit from this French innovation thanks to the reimbursement of the testbut highlighted a dramatic underestimation of the figures for tests reimbursed in 2024 and of the 10,000 to 20,000 tests planned for 2025.
Endometriosis, a little-known disease that affects many women
Endometriosis is a chronic disease that affects approximately one in ten women of childbearing age. It is characterized by the presence of endometrial tissue (the tissue that lines the uterus) outside the uterus. The most common symptoms are severe pain during periods, pain during sex and fertility problems. Diagnosing endometriosis can be difficult because symptoms vary from woman to woman and can be confused with other disorders.
The saliva test developed by the company Ziwig promises to offer a rapid and non-invasive means of detecting endometriosis, which could allow better access to care for women with this condition.
A major issue for women’s health and medical research
The management of endometriosis constitutes a major issue for women’s health. In fact, it is estimated that nearly 180 million the number of women affected by this condition in the world.
The appearance of a saliva test capable of improving the early detection of endometriosis represents an important advance for patients and medical research. The hopes raised by this French innovation attest to the dynamism and excellence of our country in terms of research in the field of women’s health.
Continuing research and development efforts for the saliva test
So that the saliva test can be offered to patients and reimbursed by Social Security, it is crucial that the research teams continue their work and obtain the necessary validations from the High Authority for Health.
With this perspective for 2025, the French government shows its desire to support innovation in the field of health and to contribute to improving the care of women with endometriosis. However, there is still a long way to go, particularly to meet the growing needs of the women concerned and ensure optimal accessibility to the saliva test for all.